The two companies will provide Houston-area customers with tech-enabled, primary care clinics in five convenient, neighborhood Walgreens locations.
The Cupertino-based company has a few key advantages over its technology rivals, including privacy and the huge base of iPhone and Apple Watch users.
The VSee telehealth and telemedicine solution for the Vuzix M300XL and Vuzix Blade Smart Glasses is expected to be commercially available during Q2 2019.
Among the working group members are companies such as AT&T, Doctor on Demand, Fitbit, Google, IBM, Osso VR, Philips, Samsung, Validic and Verizon.
Such technology would enable owners of future iPhones and Apple Watches to detect things like spoiled food, body odor and perhaps even blood sugar levels.
Also announced were six Alexa healthcare skills from leading healthcare providers, payors, pharmacy benefit managers and digital health coaching companies.
The two companies aim to digitally engage their combined base of more than 5 million customers and reward them to get active and stay healthy.
The market is seemingly slowing down, but both companies see other reasons to be optimistic about digital health investment.
The agency has released a discussion paper detailing how it plans to vet and approve AI medical devices without compromising quality or patient safety.
Fund III will be invested in commercial-stage companies delivering innovation to improve patient outcomes, enhance efficiency and reduce costs.